HERSHEY – Penn State Health has enrolled its first COVID-19 patient into an experimental treatment program called convalescent plasma therapy. Access to this treatment is available through an expanded access program led by Mayo Clinic and coordinated by the U.S. Food and Drug Administration (FDA). Patients at both Penn State Health hospitals are being screened … Continue reading Penn State Health Hospitals Now Using Plasma from Recovered Patients as Possible Treatment for COVID-19